Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05545865 · ClinicalTrials.gov registry record · NA
Chardonnay Marc and Vascular Response
A NA study of Cardiovascular Diseases and Oxidative Stress, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT05545865: Recruiting NA study of Cardiovascular Diseases and Oxidative Stress, sponsored by University of California, Davis.
NCT05545865 is a NA study of Cardiovascular Diseases and Oxidative Stress that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 5 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05545865, a NA study of Cardiovascular Diseases and Oxidative Stress, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to obtain data on the potential influence of Vine to Bar product(s) containing Chardonnay marc on cardiometabolic health. These initial studies will inform the design and timing of data collection for future dietary intervention trials that will examine the influence of Chardonnay marc intake on outcomes/biomarkers of both cardiometabolic health and the gut microbiome. This includes collecting data on the potential differences in response to the products based on the unique food matrix for each of the products that will be tested. Moreover, as there is a paucity of data on the influence of cocoa flavanol intake on vascular function beyond 4 hours post intake, the response of the selected outcomes will be assessed after 6 hours of flavanol intake. This is a time point that captures the increased circulating presence of microbial derived flavanol metabolites.
Primary Outcome
measurement of microvascular function using peripheral arterial tonometry (EndoPAT2000)
Conditions Studied
Interventions
- OTHER Low Flavanol Cocoa Powder
- OTHER High Flavanol Cocoa Powder
- OTHER Vine to Bar Chocolate - 2 servings
- OTHER Vine to Bar Chocolate - 1 serving
- OTHER Vine to Bar Chocolate covered almonds
Study Locations (1)
California
- Academic Surge, University of California, Davis - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2026-08-24 |
| Phase | NA |
What NCT05545865 shows while recruiting
NCT05545865 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 5 interventions - of which Low Flavanol Cocoa Powder is the first listed.
NCT05545865 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05545865 about?
NCT05545865 is a clinical study titled "Chardonnay Marc and Vascular Response". This study aims to obtain data on the potential influence of Vine to Bar product(s) containing Chardonnay marc on cardiometabolic health. These initial studies will inform the design and timing of data collection for future dietary intervention trials that will examine the influence of Chardonnay ma...
What is the current status of trial NCT05545865?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2022-09-01. Estimated completion is 2026-08-24.
What conditions does trial NCT05545865 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Oxidative Stress, Vascular Dilation.
What interventions are being tested in trial NCT05545865?
The interventions under investigation include: Low Flavanol Cocoa Powder (OTHER), High Flavanol Cocoa Powder (OTHER), Vine to Bar Chocolate - 2 servings (OTHER), Vine to Bar Chocolate - 1 serving (OTHER), Vine to Bar Chocolate covered almonds (OTHER).
Who is sponsoring clinical trial NCT05545865?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05545865 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05545865's enrollment target sits among peer trials
5 298th of 300 higher than 1 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI